HeartBeam Inc. logo

HeartBeam Inc. (BEAT)

Market Closed
27 Jul, 20:00
NASDAQ (CM) NASDAQ (CM)
$
0. 52
+0.01
+2.5195%
$
19.17M Market Cap
- P/E Ratio
- Div Yield
157,243 Volume
- Eps
$ 0.51
Previous Close
Add Transaction
Day Range
0.5 0.54
Year Range
0.5 4
Want to track BEAT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BEAT closed today higher at $0.52, an increase of 2.5195% from yesterday's close, completing a monthly decrease of -40.823% or -$0.36. Over the past 12 months, BEAT stock lost -78.2199%.
BEAT is not paying dividends to its shareholders.
The last earnings report, released on May 07, 2026, exceeded the consensus estimates by 0.1333%. On average, the company has surpassed earnings expectations by 0.0728%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

BEAT Chart

People also search for

Inmune Bio Inc.
$ 1.73
+6.7901%
TIL
Instil Bio, Inc.
$ 7.15
+0.2805%
Atyr Pharma Inc.
$ 0.49
+3.5095%
Mereo BioPharma Group plc - ADR
$ 0.3
+4.8958%
Dyadic International Inc.
$ 1.13
-5.042%
Healthcare IT is the Next AI Growth Story: 3 Stocks to Buy Now

Healthcare IT is the Next AI Growth Story: 3 Stocks to Buy Now

Healthcare IT is emerging as AI's next growth story as providers adopt AI to cut costs & improve care. Here we present three stocks that are likely to benefit.

Zacks | 1 week ago
Bet On These 5 Top-Ranked Stocks With Increasing P/E Ratios

Bet On These 5 Top-Ranked Stocks With Increasing P/E Ratios

Tap these five stocks, W, DHR, ISRG, BEAT and CSW, with rising P/E ratios to try out an out-of-the-box approach.

Zacks | 2 weeks ago
HeartBeam (BEAT) Upgraded to Buy: Here's What You Should Know

HeartBeam (BEAT) Upgraded to Buy: Here's What You Should Know

HeartBeam (BEAT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks | 2 months ago

HeartBeam Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
JD
Jim Dushek HARBOUR INVESTMENTS Inc.
9,250 $45,140 $5,167.97 -$39,972.03 -88.55%
YA
Yinka Akinsola Blue Trust Inc.
1,928 $2,410 $1,095.88 -$1,314.12 -54.53%
W. Travis McKinney
W. Travis McKinney HB Wealth Management LLC
10,000 $24,000 $5,700 -$18,300 -76.25%
Christopher C. Powers
Christopher C. Powers Farther Finance Advisors, LLC
6,000 $4,500 $3,410.4 -$1,089.6 -24.21%
Kelly Dixon
Kelly Dixon Cannon Financial Strategists, Inc.
72,788 $153,377.5 $43,709.19 -$109,668.31 -71.5%

HeartBeam Inc. (BEAT) FAQ

What is the stock price today?

The current price is $0.52.

On which exchange is it traded?

HeartBeam Inc. is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is BEAT.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 19.17M.

Has HeartBeam Inc. ever had a stock split?

No, there has never been a stock split.

HeartBeam Inc. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Branislav Vajdic CEO
NASDAQ (CM) Exchange
42238H108 CUSIP
US Country
16 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

HeartBeam, Inc. is a pioneering medical technology company that was founded in 2015 and is headquartered in Santa Clara, California. The company specializes in the development and commercialization of advanced ambulatory electrocardiogram (ECG) solutions designed for both in-hospital and remote patient monitoring environments. HeartBeam's mission is centered on enhancing the detection and ongoing monitoring of cardiac diseases through the use of innovative technologies that provide detailed insights into cardiac electrical activity. By focusing on creating more accessible and effective diagnostic tools, HeartBeam, Inc. aims to significantly improve patient outcomes and transform the approach to cardiac care.

Products and Services

  • Three-Dimensional Vector ECG Imaging

    HeartBeam has pioneered the development of technology capable of generating three-dimensional vector images of the heart's electrical activity. This revolutionary approach offers a more comprehensive understanding of cardiac function and abnormalities, enabling healthcare providers to make more informed decisions regarding diagnosis and treatment.

  • HeartBeam AIMIGo

    HeartBeam AIMIGo represents a significant innovation in heart attack detection technology. It is a cloud-based diagnostic software system, compact enough to be the size of a credit card, designed for rapid and accurate heart attack detection outside the conventional hospital setting. This product aims to deliver immediate diagnostic capabilities to patients, potentially saving lives by enabling faster response times in critical situations.

Contact Information

Address: 2118 Walsh Avenue
Phone: 408 899 4443